Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01034579
What this trial is testing

The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial

Who this might be right for
Relapsing Multiple Sclerosis
EMD Serono 324
Not applicableNot Yet RecruitingNCT06770959
What this trial is testing

Frequency of Gastrointestinal and Hepatic Manifestations Among Patients with Multiple Sclerosis, a Clinical Hospital Based Study

Who this might be right for
MS (Multiple Sclerosis)
Assiut University 80
Not applicableStudy completedNCT03651362
What this trial is testing

Linking Optic Nerve MRI and the Retinal Axonal Loss After Optic Neuritis

Who this might be right for
Optic Neuritis
University Hospital, Lille 46
Not applicableNot Yet RecruitingNCT07645703
What this trial is testing

MS and Health Cohort

Who this might be right for
Multiple Sclerosis
Fondation Ophtalmologique Adolphe de Rothschild 2,000
Not applicableActive Not RecruitingNCT07028879
What this trial is testing

Effectiveness of a One-year Group Program for Fatigue Management in Minimally Impaired People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Hospital Clinic of Barcelona 24
Not applicableEnded earlyNCT02218879
What this trial is testing

Restoring Glutathione Synthesis With Tecfidera: An in Vivo H-MRS Single-Arm Study at 7T in Patients With RR MS

Who this might be right for
Multiple Sclerosis
Yale University 7
Not applicableStudy completedNCT04133779
What this trial is testing

Observational Study on Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Fondazione Italiana Sclerosi Multipla 1,767
Post-approval studies (Phase 4)Study completedNCT00638027
What this trial is testing

Memantine for Spasticity in MS Patients

Who this might be right for
Multiple Sclerosis
University of Rochester 21
Testing effectiveness (Phase 2)Study completedNCT03179423
What this trial is testing

Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years

Who this might be right for
Diabetes Mellitus Type 1
GeNeuro Australia PTY Ltd 64
Not applicableActive Not RecruitingNCT07473180
What this trial is testing

Effects of Qigong Therapy in MS Patients

Who this might be right for
Multiple Sclerosis
Baskent University 36
Not applicableEnded earlyNCT04948606
What this trial is testing

Exploring Diroximel Fumarate Real-world Experience in Canada and Israel

Who this might be right for
Relapsing Forms of MS
Biogen 64
Testing effectiveness (Phase 2)Study completedNCT01264848
What this trial is testing

Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency (CCSVI)

Who this might be right for
Multiple Sclerosis
Euromedic Specialist Clinics, Poland 100
Large-scale testing (Phase 3)Study completedNCT00605215
What this trial is testing

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 1,331
Not applicableStudy completedNCT06311474
What this trial is testing

Remote Assessment and Intervention for Behavior Problems in Kids With TSC

Who this might be right for
Tuberous Sclerosis
University of California, Los Angeles 101
Post-approval studies (Phase 4)Ended earlyNCT04819360
What this trial is testing

Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis

Who this might be right for
Urinary Bladder, NeurogenicMultiple Sclerosis
Brigitte Schürch 1
Not applicableStudy completedNCT01706055
What this trial is testing

Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)

Who this might be right for
Multiple Sclerosis
Bayer 629
Not applicableUnknownNCT04042415
What this trial is testing

Calorie Restriction in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingCaloric Restriction
Federico II University 93
Not applicableWithdrawnNCT04113135
What this trial is testing

The Utilization of Yoga as a Therapeutic Tool to Promote Physical Activity Behavior Change and Improved Postural Control in Individuals With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Winston Salem State University
Testing effectiveness (Phase 2)Study completedNCT01051349
What this trial is testing

Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 410
Not applicableStudy completedNCT02017808
What this trial is testing

Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months

Who this might be right for
Multiple Sclerosis
University at Buffalo 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation